Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial

Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurotrauma 2023-09, Vol.40 (17-18), p.1889-1906
Hauptverfasser: Chow, Diana Shu-Lian, Nguyen, Ashley, Park, Junghwa, Wu, Lei, Toups, Elizabeth Gardiner, Harrop, James Shields, Guest, James David, Schmitt, Karl Michael, Aarabi, Bizhan, Fehlings, Michael George, Boakye, Maxwell, Grossman, Robert Geroge
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0897-7151
1557-9042
DOI:10.1089/neu.2022.0499